Fully-human post-translationally modified antibody therapeutics
Provided are methods and compositions for the delivery of fully human post-translationally modified therapeutic monoclonal antibodies and antigen-binding fragments thereof. The fully human post-translationally modified therapeutic monoclonal antibodies may be delivered by gene therapy methods, e.g.,...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WU, ZHUUN WANG, XU DANOS, OLIVIER BRUDER, JOSEPH QIAO, CHUN-PING LIU, YE GLENN, JUSTIN GERNER, FRANZ VAN EVEREN, SHERRI MCDOUGALD, DEVIN |
| description | Provided are methods and compositions for the delivery of fully human post-translationally modified therapeutic monoclonal antibodies and antigen-binding fragments thereof. The fully human post-translationally modified therapeutic monoclonal antibodies may be delivered by gene therapy methods, e.g., as a recombinant adeno-associated virus (rAAV) vector to the appropriate tissue. Methods of manufacture of the AAV vectors, pharmaceutical compositions and methods of treatment are also provided. In addition, provided are methods of producing therapeutic antibodies that are "biobetters" as fully human post-translationally modified. These fully human post-translationally modified therapeutic antibodies may be administered to a subject in need of treatment with the therapeutic antibody. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202106708A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202106708A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202106708A3</originalsourceid><addsrcrecordid>eNrjZLB3K83JqdTNKM1NzFMoyC8u0S0pSswrzkksyczPSwRKKeTmp2SmZaamKCTmlWQm5adUKpRkpBYlFqSWlmQmF_MwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUkviQcCMDI0MDM3MDC0djYtQAAA-nMiA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Fully-human post-translationally modified antibody therapeutics</title><source>esp@cenet</source><creator>WU, ZHUUN ; WANG, XU ; DANOS, OLIVIER ; BRUDER, JOSEPH ; QIAO, CHUN-PING ; LIU, YE ; GLENN, JUSTIN ; GERNER, FRANZ ; VAN EVEREN, SHERRI ; MCDOUGALD, DEVIN</creator><creatorcontrib>WU, ZHUUN ; WANG, XU ; DANOS, OLIVIER ; BRUDER, JOSEPH ; QIAO, CHUN-PING ; LIU, YE ; GLENN, JUSTIN ; GERNER, FRANZ ; VAN EVEREN, SHERRI ; MCDOUGALD, DEVIN</creatorcontrib><description>Provided are methods and compositions for the delivery of fully human post-translationally modified therapeutic monoclonal antibodies and antigen-binding fragments thereof. The fully human post-translationally modified therapeutic monoclonal antibodies may be delivered by gene therapy methods, e.g., as a recombinant adeno-associated virus (rAAV) vector to the appropriate tissue. Methods of manufacture of the AAV vectors, pharmaceutical compositions and methods of treatment are also provided. In addition, provided are methods of producing therapeutic antibodies that are "biobetters" as fully human post-translationally modified. These fully human post-translationally modified therapeutic antibodies may be administered to a subject in need of treatment with the therapeutic antibody.</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210216&DB=EPODOC&CC=TW&NR=202106708A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210216&DB=EPODOC&CC=TW&NR=202106708A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WU, ZHUUN</creatorcontrib><creatorcontrib>WANG, XU</creatorcontrib><creatorcontrib>DANOS, OLIVIER</creatorcontrib><creatorcontrib>BRUDER, JOSEPH</creatorcontrib><creatorcontrib>QIAO, CHUN-PING</creatorcontrib><creatorcontrib>LIU, YE</creatorcontrib><creatorcontrib>GLENN, JUSTIN</creatorcontrib><creatorcontrib>GERNER, FRANZ</creatorcontrib><creatorcontrib>VAN EVEREN, SHERRI</creatorcontrib><creatorcontrib>MCDOUGALD, DEVIN</creatorcontrib><title>Fully-human post-translationally modified antibody therapeutics</title><description>Provided are methods and compositions for the delivery of fully human post-translationally modified therapeutic monoclonal antibodies and antigen-binding fragments thereof. The fully human post-translationally modified therapeutic monoclonal antibodies may be delivered by gene therapy methods, e.g., as a recombinant adeno-associated virus (rAAV) vector to the appropriate tissue. Methods of manufacture of the AAV vectors, pharmaceutical compositions and methods of treatment are also provided. In addition, provided are methods of producing therapeutic antibodies that are "biobetters" as fully human post-translationally modified. These fully human post-translationally modified therapeutic antibodies may be administered to a subject in need of treatment with the therapeutic antibody.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB3K83JqdTNKM1NzFMoyC8u0S0pSswrzkksyczPSwRKKeTmp2SmZaamKCTmlWQm5adUKpRkpBYlFqSWlmQmF_MwsKYl5hSn8kJpbgZFN9cQZw_d1IL8-NTigsTk1LzUkviQcCMDI0MDM3MDC0djYtQAAA-nMiA</recordid><startdate>20210216</startdate><enddate>20210216</enddate><creator>WU, ZHUUN</creator><creator>WANG, XU</creator><creator>DANOS, OLIVIER</creator><creator>BRUDER, JOSEPH</creator><creator>QIAO, CHUN-PING</creator><creator>LIU, YE</creator><creator>GLENN, JUSTIN</creator><creator>GERNER, FRANZ</creator><creator>VAN EVEREN, SHERRI</creator><creator>MCDOUGALD, DEVIN</creator><scope>EVB</scope></search><sort><creationdate>20210216</creationdate><title>Fully-human post-translationally modified antibody therapeutics</title><author>WU, ZHUUN ; WANG, XU ; DANOS, OLIVIER ; BRUDER, JOSEPH ; QIAO, CHUN-PING ; LIU, YE ; GLENN, JUSTIN ; GERNER, FRANZ ; VAN EVEREN, SHERRI ; MCDOUGALD, DEVIN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202106708A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2021</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>WU, ZHUUN</creatorcontrib><creatorcontrib>WANG, XU</creatorcontrib><creatorcontrib>DANOS, OLIVIER</creatorcontrib><creatorcontrib>BRUDER, JOSEPH</creatorcontrib><creatorcontrib>QIAO, CHUN-PING</creatorcontrib><creatorcontrib>LIU, YE</creatorcontrib><creatorcontrib>GLENN, JUSTIN</creatorcontrib><creatorcontrib>GERNER, FRANZ</creatorcontrib><creatorcontrib>VAN EVEREN, SHERRI</creatorcontrib><creatorcontrib>MCDOUGALD, DEVIN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WU, ZHUUN</au><au>WANG, XU</au><au>DANOS, OLIVIER</au><au>BRUDER, JOSEPH</au><au>QIAO, CHUN-PING</au><au>LIU, YE</au><au>GLENN, JUSTIN</au><au>GERNER, FRANZ</au><au>VAN EVEREN, SHERRI</au><au>MCDOUGALD, DEVIN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Fully-human post-translationally modified antibody therapeutics</title><date>2021-02-16</date><risdate>2021</risdate><abstract>Provided are methods and compositions for the delivery of fully human post-translationally modified therapeutic monoclonal antibodies and antigen-binding fragments thereof. The fully human post-translationally modified therapeutic monoclonal antibodies may be delivered by gene therapy methods, e.g., as a recombinant adeno-associated virus (rAAV) vector to the appropriate tissue. Methods of manufacture of the AAV vectors, pharmaceutical compositions and methods of treatment are also provided. In addition, provided are methods of producing therapeutic antibodies that are "biobetters" as fully human post-translationally modified. These fully human post-translationally modified therapeutic antibodies may be administered to a subject in need of treatment with the therapeutic antibody.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_TW202106708A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | Fully-human post-translationally modified antibody therapeutics |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T22%3A15%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WU,%20ZHUUN&rft.date=2021-02-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202106708A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |